{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:58:53Z","timestamp":1790647133448,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-4598-13-212","type":"journal-article","created":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T15:33:47Z","timestamp":1410536027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["MicroRNA-21 inhibits p57Kip2 expression in prostate cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Sweta","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim H-M","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakim","family":"Bouamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Zhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,12]]},"reference":[{"key":"1409_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5483\/BMBRep.2003.36.1.060","volume":"36","author":"MT Park","year":"2003","unstructured":"Park MT, Lee SJ: Cell cycle and cancer. J Biochem Mol Biol. 2003, 36: 60-65. 10.5483\/BMBRep.2003.36.1.060","journal-title":"J Biochem Mol Biol"},{"key":"1409_CR2","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1101\/gad.9.6.650","volume":"9","author":"S Matsuoka","year":"1995","unstructured":"Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 1995, 9: 650-662. 10.1101\/gad.9.6.650","journal-title":"Genes Dev"},{"key":"1409_CR3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/jmg.36.7.518","volume":"36","author":"WW Lam","year":"1999","unstructured":"Lam WW, Hatada I, Ohishi S, Mukai T, Joyce JA, Cole TR, Donnai D, Reik W, Schofield PN, Maher ER: Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet. 1999, 36: 518-523.","journal-title":"J Med Genet"},{"key":"1409_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1101\/gad.11.8.973","volume":"11","author":"Y Yan","year":"1997","unstructured":"Yan Y, Frisen J, Lee MH, Massague J, Barbacid M: Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 1997, 11: 973-983. 10.1101\/gad.11.8.973","journal-title":"Genes Dev"},{"key":"1409_CR5","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1158\/0008-5472.CAN-08-0073","volume":"68","author":"RJ Jin","year":"2008","unstructured":"Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW, Wills ML, Logan SK, Zhang P, Matusik RJ: Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Res. 2008, 68: 3601-3608. 10.1158\/0008-5472.CAN-08-0073","journal-title":"Cancer Res"},{"key":"1409_CR6","first-page":"50","volume":"2011","author":"E Kavanagh","year":"1816","unstructured":"Kavanagh E, Joseph B: The hallmarks of CDKN1C (p57, KIP2) in cancer. Biochim Biophys Acta. 1816, 2011: 50-56.","journal-title":"Biochim Biophys Acta"},{"key":"1409_CR7","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1182\/blood-2001-11-0026","volume":"100","author":"Y Li","year":"2002","unstructured":"Li Y, Nagai H, Ohno T, Yuge M, Hatano S, Ito E, Mori N, Saito H, Kinoshita T: Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood. 2002, 100: 2572-2577. 10.1182\/blood-2001-11-0026","journal-title":"Blood"},{"key":"1409_CR8","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.leukres.2009.06.028","volume":"34","author":"K Hagiwara","year":"2010","unstructured":"Hagiwara K, Li Y, Kinoshita T, Kunishma S, Ohashi H, Hotta T, Nagai H: Aberrant DNA methylation of the p57KIP2 gene is a sensitive biomarker for detecting minimal residual disease in diffuse large B cell lymphoma. Leuk Res. 2010, 34: 50-54. 10.1016\/j.leukres.2009.06.028","journal-title":"Leuk Res"},{"key":"1409_CR9","doi-asserted-by":"publisher","first-page":"10231","DOI":"10.1073\/pnas.1831009100","volume":"100","author":"T Kamura","year":"2003","unstructured":"Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H, Hatakeyama S, Nakayama K, Nakayama KI: Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc Natl Acad Sci U S A. 2003, 100: 10231-10236. 10.1073\/pnas.1831009100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1409_CR10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/ijc.24650","volume":"126","author":"DF Calvisi","year":"2010","unstructured":"Calvisi DF, Pinna F, Ladu S, Muroni MR, Frau M, Demartis I, Tomasi ML, Sini M, Simile MM, Seddaiu MA, Feo F, Pascale RM: The degradation of cell cycle regulators by SKP2\/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. Int J Cancer J Int du Cancer. 2010, 126: 1275-1281.","journal-title":"Int J Cancer J Int du Cancer"},{"key":"1409_CR11","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1038\/onc.2008.178","volume":"27","author":"F Fornari","year":"2008","unstructured":"Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin GA, Grazi GL, Giovannini C, Croce CM, Bolondi L, Negrini M: MiR-221 controls CDKN1C\/p57 and CDKN1B\/p27 expression in human hepatocellular carcinoma. Oncogene. 2008, 27: 5651-5661. 10.1038\/onc.2008.178","journal-title":"Oncogene"},{"key":"1409_CR12","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/stem.84","volume":"27","author":"S Sengupta","year":"2009","unstructured":"Sengupta S, Nie J, Wagner RJ, Yang C, Stewart R, Thomson JA: MicroRNA 92b controls the G1\/S checkpoint gene p57 in human embryonic stem cells. Stem Cells. 2009, 27: 1524-1528. 10.1002\/stem.84","journal-title":"Stem Cells"},{"key":"1409_CR13","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1093\/nar\/gkp002","volume":"37","author":"YK Kim","year":"2009","unstructured":"Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK, Kim VN: Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009, 37: 1672-1681. 10.1093\/nar\/gkp002","journal-title":"Nucleic Acids Res"},{"key":"1409_CR14","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1158\/0008-5472.CAN-07-6754","volume":"68","author":"R Medina","year":"2008","unstructured":"Medina R, Zaidi SK, Liu CG, Stein JL, van Wijnen AJ, Croce CM, Stein GS: MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res. 2008, 68: 2773-2780. 10.1158\/0008-5472.CAN-07-6754","journal-title":"Cancer Res"},{"key":"1409_CR15","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1158\/0008-5472.CAN-04-4407","volume":"65","author":"D Lodygin","year":"2005","unstructured":"Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H: Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res. 2005, 65: 4218-4227. 10.1158\/0008-5472.CAN-04-4407","journal-title":"Cancer Res"},{"key":"1409_CR16","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1038\/onc.2013.374","volume":"33","author":"S Mishra","year":"2014","unstructured":"Mishra S, Deng JJ, Gowda PS, Rao MK, Lin CL, Chen CL, Huang T, Sun LZ: Androgen receptor and microRNA-21 axis downregulates transforming growth factor beta receptor II (TGFBR2) expression in prostate cancer. Oncogene. 2014, 33: 4097-4106. 10.1038\/onc.2013.374","journal-title":"Oncogene"},{"key":"1409_CR17","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1002\/pros.22499","volume":"72","author":"J Shen","year":"2012","unstructured":"Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC, Santella RM: Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate. 2012, 72: 1469-1477. 10.1002\/pros.22499","journal-title":"Prostate"},{"key":"1409_CR18","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1101\/gr.139758.112","volume":"23","author":"J Hausser","year":"2013","unstructured":"Hausser J, Syed AP, Bilen B, Zavolan M: Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res. 2013, 23: 604-615. 10.1101\/gr.139758.112","journal-title":"Genome Res"},{"key":"1409_CR19","first-page":"3042","volume":"56","author":"M Nagabhushan","year":"1996","unstructured":"Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, Schwartz S, Kung HJ, de Vere White RW, Gumerlock PH, Resnick MI, Amini SB, Pretlow TG: CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res. 1996, 56: 3042-3046.","journal-title":"Cancer Res"},{"key":"1409_CR20","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/carcin\/bgr220","volume":"32","author":"H Guo","year":"2011","unstructured":"Guo H, Lv Y, Tian T, Hu TH, Wang WJ, Sui X, Jiang L, Ruan ZP, Nan KJ: Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma. Carcinogenesis. 2011, 32: 1897-1904. 10.1093\/carcin\/bgr220","journal-title":"Carcinogenesis"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-13-212.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T12:59:28Z","timestamp":1717333168000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-13-212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,12]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1409"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-13-212","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,12]]},"assertion":[{"value":"5 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"212"}}